Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Jones

Showing results (11-20 of 463) with videos related to

Pageof 47
Sort By:
Therapeutic Delivery|July 27, 2012
Intestinal receptor targeting for peptide delivery: an expert's personal perspective on reasons for failure and new opportunitiesGregory Russell-Jones
Journal of the American Academy of Dermatology|January 11, 2003
World Health Organization classification of hematopoietic and lymphoid tissues: implications for dermatologyRobin Russell-Jones
Clinical and Experimental Dermatology|February 15, 2000
Interferon-alpha therapy for melanomaR Russell-Jones
The British Journal of Dermatology|February 13, 2001
Immunophenotyping of Sézary cellsR Russell-Jones
Journal of the Royal College of Physicians of London|September 1, 1996
The future of dermatology--in hospital or out?R Russell-Jones
The British Journal of Dermatology|February 17, 1999
Primary cutaneous B-cell lymphoma: how useful is the new European Organization for Research and Treatment of Cancer (EORTC) classification?R Russell-Jones
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|August 13, 2004
Insulin detemir: improving the predictability of glycaemic controlD Russell-Jones
The British Journal of Dermatology|November 26, 2005
Sentinel node and survival in melanomaR Russell-Jones
The British Journal of Dermatology|June 9, 2016
The value of sentinel lymph node biopsy in Merkel cell carcinomaR Russell-Jones
Molecular and Cellular Endocrinology|December 2, 2008
Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogueDavid Russell-Jones
Pageof 47

Showing results (11-20 of 463) with videos related to

Sort By:
Pageof 47
Therapeutic Delivery|July 27, 2012
Intestinal receptor targeting for peptide delivery: an expert's personal perspective on reasons for failure and new opportunitiesGregory Russell-Jones
Journal of the American Academy of Dermatology|January 11, 2003
World Health Organization classification of hematopoietic and lymphoid tissues: implications for dermatologyRobin Russell-Jones
Clinical and Experimental Dermatology|February 15, 2000
Interferon-alpha therapy for melanomaR Russell-Jones
The British Journal of Dermatology|February 13, 2001
Immunophenotyping of Sézary cellsR Russell-Jones
Journal of the Royal College of Physicians of London|September 1, 1996
The future of dermatology--in hospital or out?R Russell-Jones
The British Journal of Dermatology|February 17, 1999
Primary cutaneous B-cell lymphoma: how useful is the new European Organization for Research and Treatment of Cancer (EORTC) classification?R Russell-Jones
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|August 13, 2004
Insulin detemir: improving the predictability of glycaemic controlD Russell-Jones
The British Journal of Dermatology|November 26, 2005
Sentinel node and survival in melanomaR Russell-Jones
The British Journal of Dermatology|June 9, 2016
The value of sentinel lymph node biopsy in Merkel cell carcinomaR Russell-Jones
Molecular and Cellular Endocrinology|December 2, 2008
Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogueDavid Russell-Jones
Pageof 47